Market Overview

Fannie And Freddie Face An Uncertain Future

Fannie And Freddie Face An Uncertain Future
Related FNMA
Tariffs, Drug Prices, Legislative Gridlock: What Economists Are Watching Following The Midterm Election
Here's What's At Stake For Your Investments In The 2018 Midterms
Mortgage lender profit outlook falls for nine straight quarters: Fannie Mae (Seeking Alpha)
Related FMCC
The Home Affordable Refinance Program Is Ending Again, For Real This Time
C-Suite Shakeups Could Change The Course Of Fannie And Freddie's Conservatorship
Mortgage lender profit outlook falls for nine straight quarters: Fannie Mae (Seeking Alpha)

Federal National Mortgage Association (OTC: FNMA) and Federal Home Loan Mortgage Corp (OTC: FMCC) investors have gotten a lot of good news about the government-sponsored enterprises’ future in recent months. Unfortunately, that good news hasn't been reflected in the stocks’ share prices.

In the past month, Fannie Mae and Feddie Mac’s common stocks have declined by more than 15 percent each, and Height Securities analyst Edwin Groshans says there's simply too much uncertainty remaining when it comes to Fannie and Freddie.

More Waiting Ahead

According to Groshans, shareholders will likely not be getting the resolution they had hoped for from a housing finance bill in 2018.

“Based on the latest reports, the gaps in the Senate’s draft bill reforming housing finance and the GSEs, the concept of keeping the newcos under government control after raising capital, and the limited amount of time before the August break appear to create significant hurdles that will likely work against the legislation becoming law in 2018,” Groshans wrote in a Thursday note.

Bloomberg has reported the GSE’s future will be decided by a section of the new housing finance bill that is currently marked “open pending further discussion.”

The End Of Fannie And Freddie?

Groshans says the Bloomberg report suggests the government will relinquish its senior preferred shares of Fannie and Freddie stock, leaving the door open for senior preferred shareholders. Common shareholders may be left out in the cold.

“The article also noted that the yet-to-be-released draft bill technically kills Fannie Mae and Freddie Mac while preserving their core operations,” Groshans wrote.

The new report suggests the Federal Housing Finance Agency could place the GSEs into receivership and liquidate their assets, transitioning the company’s personnel and infrastructure to entirely new entities. Groshans said this approach would cost taxpayers hundreds of billions of dollars and make the government’s Fannie and Freddie warrants worthless.

Price Action

Investors certainly didn’t like what they saw from the Bloomberg report on Thursday. Fannie and Freddie common shares both traded down by more than 2.7 percent on Thursday.

Related Links:

Fannie Mae, Freddie Mac Preferred Shareholders Could See Huge Upside From Conversion Process

‘A Sea Change Underway': Fannie Mae, Freddie Mac To Retain Capital Again

Posted-In: Edwin Groshans fannie mae freddie macAnalyst Color Politics Top Stories Analyst Ratings General Best of Benzinga


Related Articles (FMCC + FNMA)

View Comments and Join the Discussion!

Latest Ratings

MOSJP MorganDowngrades33.0
BACKeefe Bruyette & WoodsDowngrades29.0
AMTMorgan StanleyDowngrades170.0
EBAYMorgan StanleyDowngrades33.0
UNITMorgan StanleyDowngrades16.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

Mid-Day Market Update: Buckle Drops After December Sales Results; ChemoCentryx Shares Spike Higher

6 Budget Mistakes To Avoid In 2018